Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Opdualag
Opdualag
Bristol Myers axes German launch of new cancer drug, citing pricing hurdles
Bristol Myers axes German launch of new cancer drug, citing pricing hurdles
Endpoints
Bristol Myers Squibb
Germany
Opdivo
Opdualag
Flag link:
A year of two halves for US approvals
A year of two halves for US approvals
EP Vantage
FDA
drug approvals
Mounjaro
Eli Lilly
Vabysmo
Roche
Opdualag
Bristol Myers Squibb
Carvykti
JNJ
Vtama
Roivant
Pluvicto
Novartis
Flag link:
What’s next for Bristol Myers' relatlimab?
What’s next for Bristol Myers' relatlimab?
EP Vantage
Bristol Myers Squibb
relatilimab
Opdivo
Opdualag
melanoma
Flag link:
